What We're Reading: Page 172
Industry reads hand-picked by our editors
May 11, 2021
-
Associated Press
AIDS virus used in gene therapy to fix 'bubble baby' disease
-
BioSpace
With $52 Million Series A, Appia Bio Anticipates a Bright Future in Cell Therapy
-
Reuters
Vietnam seeks mRNA tech transfer amid COVID-19 vaccine supply issues
-
C&EN
Fear and confusion continue over research interactions with China
May 10, 2021
-
The Washington Post
Maker of latest experimental vaccine not expected to seek authorization until June at the earliest
-
FierceBiotech
Abingworth raises $582M clinical co-development fund amid rising biotech interest
-
Financial Times
Vaccine diplomacy: Inside Biden's decision on Covid patents
-
Evaluate Vantage
Europe's venture boom trails the US
May 07, 2021
-
The Financial Times
Angela Merkel rejects US move to waive patents on vaccines
-
The Wall Street Journal
Elizabeth Holmes Fights to Shield Wealth From Jury
-
MSNBC
Former FDA Commissioner talks return to normal life, says he will vaccinate his kids when eligible
-
Evaluate Vantage
At long last, tremelimumab scores
May 06, 2021
-
The Washington Post
Pfizer-BioNTech vaccine offers strong protection against key variants of concern, real-world data from Qatar shows
-
Evaluate Vantage
A surprise Keytruda approval, and what it means for biotech
-
Nature
Why some researchers oppose unrestricted sharing of coronavirus data
-
NPR
They Desperately Need COVID Vaccines. So Why Are Some Countries Throwing Out Doses?
May 05, 2021
May 04, 2021
-
The New York Times
F.D.A. Set to Authorize Pfizer Vaccine for Adolescents by Early Next Week
-
Reuters
Big three drug distributors blame doctors, regulators in trial over opioid epidemic
-
Science
What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest
-
Fierce Biotech
Astellas quietly cuts Cytokinetics R&D pact as $450M-plus in biobucks goes up in smoke
May 03, 2021
-
Fortune
GoodRx helps people afford drugs. But is it improving health care or profiting off a broken system?
-
NBC News
FDA wants 'significant' amount of extra data on AstraZeneca's Covid vaccine
-
STAT
With Amgen's KRAS cancer drug, worry about pricing, not safety
-
San Diego Union-Tribune
So coronavirus vaccines aren’t perfect. They’re still very, very effective
Previous
